BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 14243392)

  • 1. SOLUBILITY OF FIBRIN CLOTS IN SOLUTIONS OF HEPARIN.
    TRIANTAPHYLLOPOULOS DC; TRIANTAPHYLLOPOULOS E
    Nature; 1964 Dec; 204():1096-8. PubMed ID: 14243392
    [No Abstract]   [Full Text] [Related]  

  • 2. [Electron microscopic study of the products from dissolving unstabilized fibrin with complex heparin compounds].
    Ul'ianov AM; Zhitnikova ES
    Biokhimiia; 1978; 43(4):646-52. PubMed ID: 656495
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A review of the basic mechanisms of fibrinogen to fibrin conversion and of fibrinolysis: intravascular coagulation versus primary fibrinolysis.
    Colick JA; Fisher LM
    Va Med Mon (1918); 1970 May; 97(5):310-4 passimass. PubMed ID: 4276992
    [No Abstract]   [Full Text] [Related]  

  • 4. [SHORT SURVEY ON RESEARCH LEADING TO A CLARIFICATION OF HEMOPHILIA].
    KUKOWKA A
    Z Gesamte Inn Med; 1963 Aug; 18():730-8. PubMed ID: 14083669
    [No Abstract]   [Full Text] [Related]  

  • 5. The conversion of fibrinogen to fibrin. XIII. Dissolution of fibrin and inhibition of clotting by various neutral salts.
    SHULMAN S; KATZ S; FERRY JD
    J Gen Physiol; 1953 Jul; 36(6):759-66. PubMed ID: 13069679
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Low-molecular heparin complex formation with the blood coagulation proteins--thrombin and fibrinogen].
    Kudriashov BA; Liapina LA; Pastorova VE; Kondashevskaia MV
    Izv Akad Nauk SSSR Biol; 1992; (5):802-6. PubMed ID: 1332992
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enhancement of blood coagulation by soluble fibrin complexes.
    Hansen MS; Bang NU; Barton RD; Mattler LE
    J Exp Med; 1975 May; 141(5):944-61. PubMed ID: 805207
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cross-linking of fibrin by fibrin=stabilizing factor.
    McKee PA; Schwartz ML; Pizzo SV; Hill RL
    Ann N Y Acad Sci; 1972 Dec; 202():127-48. PubMed ID: 4565368
    [No Abstract]   [Full Text] [Related]  

  • 9. Influence of NA2-EDTA and some compounds used for dissolution of fibrin clots on the physiochemical properties of fibrinogen and fibrin.
    Godal HC; Brosstad F; Kierulf P
    Bibl Haematol; 1977; 44():151-5. PubMed ID: 104706
    [No Abstract]   [Full Text] [Related]  

  • 10. [Nature of lytic effect of fibrinogen-heparin and thyroxine-heparin complexes on fibrin].
    Kudriashov BA; Liapina LA; Molchanova LV; Rustamova BA
    Vopr Med Khim; 1970; 16(2):161-8. PubMed ID: 4247358
    [No Abstract]   [Full Text] [Related]  

  • 11. Fibrinogen and its derivatives in intravascular coagulation. A review.
    Gerrits WB
    Neth J Med; 1975; 18(1):31-44. PubMed ID: 124019
    [No Abstract]   [Full Text] [Related]  

  • 12. [METHOD OFSTUDY OF BLOOD COAGULATION BASED ON THE CHANGES IN ELECTRIC RESISTANCE OF THE FIBRINNETWORK].
    BAYOBAYO JM; ZULUAGAJARAMILLO E
    Arch Inst Farmacol Exp (Madr); 1963; 15():75-93. PubMed ID: 14049389
    [No Abstract]   [Full Text] [Related]  

  • 13. [Modern data on the chemistry and physiology of fibrinogen].
    Andreenko GV
    Usp Sovrem Biol; 1974; 77(1):51-69. PubMed ID: 4282801
    [No Abstract]   [Full Text] [Related]  

  • 14. Pathophysiology and clinical aspects of fibrinolysis and inhibition of coagulation. Experimental and clinical studies with special reference to women on oral contraceptives and selected groups of thrombosis prone patients.
    Jespersen J
    Dan Med Bull; 1988 Feb; 35(1):1-33. PubMed ID: 3277796
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The haemostatic balance in groups of thrombosis-prone patients. With particular reference to fibrinolysis in patients with myocardial infarction.
    Gram J
    Dan Med Bull; 1990 Jun; 37(3):210-34. PubMed ID: 2192835
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The aggregation of fibrin powder suspensions by fibrinogen and its measurement by a sedimentation parameter.
    Exner T; Richard KA; Kronenberg H
    Thromb Res; 1975 Aug; 7(2):315-22. PubMed ID: 1162650
    [No Abstract]   [Full Text] [Related]  

  • 17. [Role of heparin in the process of blood coagulation and fibrinolysis].
    Liapina LA
    Usp Sovrem Biol; 1977; 84(3):338-52. PubMed ID: 343416
    [No Abstract]   [Full Text] [Related]  

  • 18. Mechanism of accelerated lysis of blood clots from heparinised blood.
    Morris CJ; Williamson N; Wolf P
    Haemostasis; 1981; 10(5):245-60. PubMed ID: 7274777
    [No Abstract]   [Full Text] [Related]  

  • 19. [Analysis of lytic effect on fibrin of immobilized heparin in complex with plasma proteins].
    Platé NA; Valuev LI; Gumirova FKh; Maklakova IA
    Vopr Med Khim; 1982; 28(5):19-23. PubMed ID: 6217639
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Equilibria in the fibrinogen--fibrin conversion. 8. Polymerization of acceptor-modified fibrin monomer.
    Endres GF; Scheraga HA
    Biochemistry; 1968 Dec; 7(12):4219-26. PubMed ID: 5750166
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.